Amyris Inc (NASDAQ: AMRS), a synthetic biotechnology company, has completed the negotiation of key financial and business terms for the exclusive rights to supply two of its ingredients. The transacti...
Tag: Amyris
How The Skincare Industry Is Turning to Gene Editing in a Race Against Time
Nature-sourced ingredients in cosmetics could be replaced with sustainable products made with … [+] synthetic biology. Stable Diffusion generative algorithm. Your skincare routine might need an ...